Q3 Asset Management »

Summit Therapeutics shares owned by Q3 Asset Management

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Q3 Asset Management from 13F filings

Historical chart of Q3 Asset Management investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Q3 Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Q3 Asset Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $293k 17k 17.79
2023-03-31 $27k 16k 1.71

More positions owned by Q3 Asset Management

Q3 All Season Active Rotation Etf Etf (QVOY)
Consumer Discretionary Select Sector SPDR Fund Etf (XLY)
Schwab U.S. Large-Cap Growth ETF USD Class Etf (SCHG)
Stf Tactical Growth & Income Etf Etf (TUGN)
iShares Core S&P 500 ETF USD Class Etf (IVV)
Fidelity MSCI Communication Services Index ETF Etf (FCOM)
Invesco S&P 500 High Beta ETF USD Class Etf (SPHB)
Fidelity MSCI Financials Index ETF USD Class Etf (FNCL)
Invesco S&P 500 BuyWrite ETF USD Class Etf (PBP)
iShares Convertible Bond ETF Etf (ICVT)
Amplify Transformational Data Sharing ETF USD Class Etf (BLOK)
Janus Henderson AAA CLO ETF USD Class Etf (JAAA)
Spdr S&p 500 Etf Tr Tr Unit Etf (SPY)
iShares Broad USD High Yield Corporate Bond ETF USD Class Etf (USHY)
Vanguard Total International Bond ETF Etf (BNDX)

View all positions for Q3 Asset Management

Top funds holding Summit Therapeutics

Baker Bros. Advisors
Vanguard Group
BlackRock
FMR
T. Rowe Price Associates
State Street Corporation
Geode Capital Management
Millennium Management
Twin Tree Management
Charles Schwab Investment Management
Pictet Asset Management Holding SA
Standard Life Aberdeen
UBS Group
Rock Springs Capital Management
Jane Street

View all funds holding Summit Therapeutics